| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/02/2002 | WO2001083710A3 Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001069244A3 Method for labeling individual cells |
| 05/02/2002 | WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001064926A3 Methods and compositions to reduce or eliminate transmission of a transgene |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001059450A3 Cells expressing zinc finger protein for drug discovery |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001048209A3 Genes identified as required for proliferation of e. coli |
| 05/02/2002 | WO2001046394A3 Mammalian protein phosphatases |
| 05/02/2002 | WO2001034824A3 Methods and compositions comprising renilla gfp |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001031028A3 Mutant luciferase |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000077208A9 Gustatory receptors in drosophila |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020053098 Nucleotide sequences coding enzymatic polypeptide for use in generating poison resistant plants |
| 05/02/2002 | US20020053093 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 05/02/2002 | US20020053092 Generation and recovering transgenic stem cells; obtain gonad, inject transfection mixture, insert expression vector into genome, recover transgenic stem cells |
| 05/02/2002 | US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/02/2002 | US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy |
| 05/02/2002 | US20020052485 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 05/02/2002 | US20020052483 Intestinal trefoil proteins |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052046 Method of improving the primary energy metabolism of mammalian cell lines |
| 05/02/2002 | US20020052045 Propagating corn seeds; harvest corn, remove seeds, segment seeds, insert seed particle into container with nutrient broth, propagate seeds |
| 05/02/2002 | US20020052044 Process for the production of human cartilage implants by means of chondrocytes cultivated in vitro |
| 05/02/2002 | US20020052043 Human G-protein coupled receptors |
| 05/02/2002 | US20020052036 Mutant B-type DNA polymerases exhibiting improved performance in PCR |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | US20020052020 Novel orphan receptors |
| 05/02/2002 | US20020051997 Sf, a novel family of taste receptors |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
| 05/02/2002 | US20020051966 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 05/02/2002 | US20020051849 Includes amino acid polymer, buffered crosslinking agent, and deionized water |
| 05/02/2002 | US20020051806 Patterned substrates and methods for nerve regeneration |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051766 Treating an aliquot of patient's blood ex vivo with a stressor selected from temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering back into patient |
| 05/02/2002 | US20020051765 Method of cancer treatment |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051762 Purified populations of endothelial progenitor cells |
| 05/02/2002 | EP1201766A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 05/02/2002 | EP1201761A1 Method of constructing recombinant adenovirus vector |
| 05/02/2002 | EP1201760A1 Influenza virus vector for human dendritic cells |
| 05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201749A1 Method for producing cartilage implants using chondrocytes grown in-vitro |
| 05/02/2002 | EP1200831A1 Modulating binding site on potassium channels used for screening |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200617A2 Methods for conditional transgene expression and trait removal in plants |
| 05/02/2002 | EP1200615A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 05/02/2002 | EP1200613A2 Agrobacterium-mediated plant transformation method |
| 05/02/2002 | EP1200612A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 05/02/2002 | EP1200611A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 05/02/2002 | EP1200609A1 Method for obtaining isogenic transgenic lines |
| 05/02/2002 | EP1200608A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200600A2 Monocellular or multicellular organisms for the production of riboflavin |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200592A2 Mammalian cytokines; related reagents |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200583A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200575A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 05/02/2002 | EP1200569A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
| 05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
| 05/02/2002 | EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 05/02/2002 | EP1200561A1 Recombinant stabile cell clone, its production and use thereof |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200559A2 Muscle cells and their use in cardiac repair |
| 05/02/2002 | EP1200558A2 Avian blastodermal cell lines |
| 05/02/2002 | EP1200557A1 Method of making plant artificial chromosomes |